Literature DB >> 12177605

Enforced c-REL deficiency prolongs survival of islet allografts1.

Hua Yang1, Dolca Thomas, Daniel J Boffa, Ruchuang Ding, Baogui Li, Thangamani Muthukumar, Vijay K Sharma, Milagros Lagman, Guo-Xiong Luo, Sandip Kapur, Hsiou-Chi Liou, Wayne W Hancock, Manikkam Suthanthiran.   

Abstract

BACKGROUND: The NF-kappaB/Rel family of transcription factors regulates biologic processes ranging from apoptosis to inflammation and innate immunity. Whether c-Rel, a lymphoid-predominant member of the NF-kappaB/Rel family, is essential for transplantation immunity is not known.
METHODS: We explored the role of c-Rel in the anti-allograft repertory using mice with targeted disruption of the c-Rel gene (c-Rel-/-) as recipients of H-2 mismatched islet allografts. Allogeneic DBA/2 (H-2d) islets were transplanted into the renal subcapsular space of diabetic c-Rel-/- C57BL/6 (H-2b) mice or the c-Rel +/+ C57BL/6 wild-type mice. Islet graft survival, cellular traffic into the islet grafts and their phenotype, and intragraft expression of cytokines and cytotoxic attack molecules were determined at the protein (by immunohistochemistry) and mRNA (by real-time quantitative polymerase chain reaction) levels.
RESULTS: We found superior islet graft survival in the c-Rel-/- recipients compared to c-Rel+/+ C57BL/6 recipients. Splenocytes from c-Rel-/- mice proliferated poorly compared to splenocytes from the c-Rel+/+ mice on stimulation with anti-CD3 mAbs or Con A. Peri-islet infiltration composed of T lymphocytes and macrophages was found in both c-Rel+/+ recipients and c-Rel-/- recipients, but intra-islet infiltration was observed only in c-Rel+/+ recipients. Immunohistologic and molecular studies showed impaired T helper-type 1 immunity and decreased intragraft expression of cytotoxic attack molecules perforin and granzyme B in c-Rel-/- recipients as compared to wild-type recipients.
CONCLUSIONS: Our results demonstrate that c-Rel is essential for robust rejection of islet allografts and support the idea that strategies that impair c-Rel function may be of value for constraining alloimmunity and facilitating survival of allogafts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177605     DOI: 10.1097/00007890-200208150-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

Review 1.  Role of T cell-nuclear factor κB in transplantation.

Authors:  Luciana L Molinero; Maria-Luisa Alegre
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 2.  Immunological synapse: a multi-protein signalling cellular apparatus for controlling gene expression.

Authors:  Kartika Padhan; Rajat Varma
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

3.  Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.

Authors:  Hua Yang; Elaine Y Cheng; Vijay K Sharma; Mila Lagman; Christina Chang; Ping Song; Ruchuang Ding; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

4.  Role of T-cell-specific nuclear factor κB in islet allograft rejection.

Authors:  Delia Lozano Porras; Ying Wang; Ping Zhou; Luciana L Molinero; Maria-Luisa Alegre
Journal:  Transplantation       Date:  2012-05-27       Impact factor: 4.939

5.  Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction.

Authors:  Jie Wu; Hedong Zhang; Xiaomin Shi; Xiang Xiao; Yihui Fan; Laurie J Minze; Jin Wang; Rafik M Ghobrial; Jiahong Xia; Roger Sciammas; Xian C Li; Wenhao Chen
Journal:  Immunity       Date:  2017-12-05       Impact factor: 31.745

6.  Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function.

Authors:  Elaine Y Cheng; Vijay K Sharma; Christina Chang; Ruchuang Ding; Anthony C Allison; David B Leeser; Manikkam Suthanthiran; Hua Yang
Journal:  Transplantation       Date:  2010-10-15       Impact factor: 4.939

7.  A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.

Authors:  Yusuke Shono; Andrea Z Tuckett; Samedy Ouk; Hsiou-Chi Liou; Grégoire Altan-Bonnet; Jennifer J Tsai; Jennifer E Oyler; Odette M Smith; Mallory L West; Natalie V Singer; Ekaterina Doubrovina; Dmitry Pankov; Chandresh V Undhad; George F Murphy; Cecilia Lezcano; Chen Liu; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  Cancer Discov       Date:  2014-02-18       Impact factor: 39.397

Review 8.  Anti-inflammatory strategies to enhance islet engraftment and survival.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

9.  Inhibition of nuclear factor-κB activation in pancreatic β-cells has a protective effect on allogeneic pancreatic islet graft survival.

Authors:  Roy Eldor; Roy Abel; Dror Sever; Gad Sadoun; Amnon Peled; Ronit Sionov; Danielle Melloul
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

10.  RNAi-mediated c-Rel silencing leads to apoptosis of B cell tumor cells and suppresses antigenic immune response in vivo.

Authors:  Wenzhi Tian; Hsiou-Chi Liou
Journal:  PLoS One       Date:  2009-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.